{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:25:15Z","timestamp":1792686315595,"version":"4.5.0"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-024-02082-z","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T10:49:40Z","timestamp":1724323780000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Circular RNAs in tumor immunity and immunotherapy"],"prefix":"10.1186","volume":"23","author":[{"given":"Wenjie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingshi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haimin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6624-5532","authenticated-orcid":false,"given":"Shibin","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8573-0445","authenticated-orcid":false,"given":"Kaishan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,21]]},"reference":[{"issue":"3","key":"2082_CR1","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.molcel.2018.06.034","volume":"71","author":"X Li","year":"2018","unstructured":"Li X, Yang L, Chen LL. The biogenesis, functions, and challenges of circular RNAs. Mol Cell. 2018;71(3):428\u201342.","journal-title":"Mol Cell"},{"issue":"8","key":"2082_CR2","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.ymthe.2019.07.001","volume":"27","author":"L Santer","year":"2019","unstructured":"Santer L, B\u00e4r C, Thum T. Circular RNAs: a novel class of functional RNA molecules with a therapeutic perspective. Mol Ther. 2019;27(8):1350\u201363.","journal-title":"Mol Ther"},{"issue":"2","key":"2082_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.canlet.2015.06.003","volume":"365","author":"S Qu","year":"2015","unstructured":"Qu S, et al. Circular RNA: a new star of noncoding RNAs. Cancer Lett. 2015;365(2):141\u20138.","journal-title":"Cancer Lett"},{"issue":"3","key":"2082_CR4","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41571-021-00585-y","volume":"19","author":"LS Kristensen","year":"2022","unstructured":"Kristensen LS, et al. The emerging roles of circRNAs in cancer and oncology. Nat Rev Clin Oncol. 2022;19(3):188\u2013206.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"2082_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13045-016-0370-2","volume":"10","author":"Y Dong","year":"2017","unstructured":"Dong Y, et al. Circular RNAs in cancer: an emerging key player. J Hematol Oncol. 2017;10(1):2.","journal-title":"J Hematol Oncol"},{"issue":"7648","key":"2082_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature21715","volume":"544","author":"T Akta\u015f","year":"2017","unstructured":"Akta\u015f T, et al. DHX9 suppresses RNA processing defects originating from the Alu invasion of the human genome. Nature. 2017;544(7648):115\u20139.","journal-title":"Nature"},{"issue":"4","key":"2082_CR7","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.cell.2018.12.021","volume":"176","author":"JN Vo","year":"2019","unstructured":"Vo JN, et al. The landscape of circular RNA in cancer. Cell. 2019;176(4):869-881.e13.","journal-title":"Cell"},{"issue":"10","key":"2082_CR8","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1016\/j.ymthe.2019.09.001","volume":"27","author":"J Wang","year":"2019","unstructured":"Wang J, et al. ncRNA-encoded peptides or proteins and cancer. Mol Ther. 2019;27(10):1718\u201325.","journal-title":"Mol Ther"},{"issue":"4","key":"2082_CR9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.trecan.2020.01.012","volume":"6","author":"J Li","year":"2020","unstructured":"Li J, et al. Circular RNAs in cancer: biogenesis, function, and clinical significance. Trends Cancer. 2020;6(4):319\u201336.","journal-title":"Trends Cancer"},{"issue":"6","key":"2082_CR10","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.ymthe.2022.12.005","volume":"31","author":"J Qadir","year":"2023","unstructured":"Qadir J, et al. CircRNAs regulate the crosstalk between inflammation and tumorigenesis: the bilateral association and molecular mechanisms. Mol Ther. 2023;31(6):1514\u201332.","journal-title":"Mol Ther"},{"issue":"4","key":"2082_CR11","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1080\/15548627.2019.1634945","volume":"16","author":"X Chen","year":"2020","unstructured":"Chen X, et al. Circular RNA circHIPK3 modulates autophagy via MIR124-3p-STAT3-PRKAA\/AMPK\u03b1 signaling in STK11 mutant lung cancer. Autophagy. 2020;16(4):659\u201371.","journal-title":"Autophagy"},{"issue":"12","key":"2082_CR12","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.7150\/thno.32796","volume":"9","author":"YJ Zhu","year":"2019","unstructured":"Zhu YJ, et al. Circular RNAs negatively regulate cancer stem cells by physically binding FMRP against CCAR1 complex in hepatocellular carcinoma. Theranostics. 2019;9(12):3526\u201340.","journal-title":"Theranostics"},{"issue":"1","key":"2082_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12943-019-1060-9","volume":"18","author":"J Bi","year":"2019","unstructured":"Bi J, et al. Circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p\/p21 axis and acts as a prognostic factor of recurrence. Mol Cancer. 2019;18(1):133.","journal-title":"Mol Cancer"},{"issue":"1","key":"2082_CR14","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12943-020-01265-8","volume":"19","author":"J Bi","year":"2020","unstructured":"Bi J, et al. Correction to: circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p\/p21 axis and acts as a prognostic factor of recurrence. Mol Cancer. 2020;19(1):148.","journal-title":"Mol Cancer"},{"issue":"1","key":"2082_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13046-020-01648-1","volume":"39","author":"W Hong","year":"2020","unstructured":"Hong W, et al. Circular RNA circ-CPA4\/ let-7 miRNA\/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC). J Exp Clin Cancer Res. 2020;39(1):149.","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"2082_CR16","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nsmb.2959","volume":"22","author":"Z Li","year":"2015","unstructured":"Li Z, et al. Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol. 2015;22(3):256\u201364.","journal-title":"Nat Struct Mol Biol"},{"key":"2082_CR17","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.omtn.2019.11.023","volume":"19","author":"X Shi","year":"2020","unstructured":"Shi X, et al. circRNAs and exosomes: a mysterious frontier for human cancer. Mol Ther Nucleic Acids. 2020;19:384\u201392.","journal-title":"Mol Ther Nucleic Acids"},{"key":"2082_CR18","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.omtn.2021.11.027","volume":"27","author":"WW Du","year":"2022","unstructured":"Du WW, et al. Promotion of tumor progression by exosome transmission of circular RNA circSKA3. Mol Ther Nucleic Acids. 2022;27:276\u201392.","journal-title":"Mol Ther Nucleic Acids"},{"key":"2082_CR19","doi-asserted-by":"publisher","first-page":"216245","DOI":"10.1016\/j.canlet.2023.216245","volume":"566","author":"Z Lin","year":"2023","unstructured":"Lin Z, et al. Exosomal circRNAs in cancer: implications for therapy resistance and biomarkers. Cancer Lett. 2023;566:216245.","journal-title":"Cancer Lett"},{"issue":"6","key":"2082_CR20","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41419-022-04949-9","volume":"13","author":"B Tuo","year":"2022","unstructured":"Tuo B, et al. Roles of exosomal circRNAs in tumour immunity and cancer progression. Cell Death Dis. 2022;13(6):539.","journal-title":"Cell Death Dis"},{"key":"2082_CR21","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.semcancer.2020.12.026","volume":"83","author":"A Beilerli","year":"2022","unstructured":"Beilerli A, et al. Circular RNAs as biomarkers and therapeutic targets in cancer. Semin Cancer Biol. 2022;83:242\u201352.","journal-title":"Semin Cancer Biol"},{"issue":"12","key":"2082_CR22","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s13238-020-00799-3","volume":"12","author":"G Wen","year":"2021","unstructured":"Wen G, Zhou T, Gu W. The potential of using blood circular RNA as liquid biopsy biomarker for human diseases. Protein Cell. 2021;12(12):911\u201346.","journal-title":"Protein Cell"},{"issue":"3","key":"2082_CR23","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1016\/S1470-2045(19)30823-X","volume":"21","author":"AK Singh","year":"2020","unstructured":"Singh AK, McGuirk JP. CAR T cells: continuation in a revolution of immunotherapy. Lancet Oncol. 2020;21(3):e168\u201378.","journal-title":"Lancet Oncol"},{"key":"2082_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2020.02.002","volume":"476","author":"S Xu","year":"2020","unstructured":"Xu S, et al. Immunotherapy for glioma: current management and future application. Cancer Lett. 2020;476:1\u201312.","journal-title":"Cancer Lett"},{"issue":"1","key":"2082_CR25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11684-018-0678-0","volume":"13","author":"M Zhang","year":"2019","unstructured":"Zhang M, et al. Monitoring checkpoint inhibitors: predictive biomarkers in immunotherapy. Front Med. 2019;13(1):32\u201344.","journal-title":"Front Med"},{"issue":"Pt 4","key":"2082_CR26","doi-asserted-by":"publisher","first-page":"124929","DOI":"10.1016\/j.ijbiomac.2023.124929","volume":"242","author":"Y He","year":"2023","unstructured":"He Y, et al. The role of circular RNA in tumor microenvironment and immunotherapy. Int J Biol Macromol. 2023;242(Pt 4):124929.","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"2082_CR27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41419-023-05647-w","volume":"14","author":"L Guan","year":"2023","unstructured":"Guan L, et al. Regulation of the tumor immune microenvironment by cancer-derived circular RNAs. Cell Death Dis. 2023;14(2):132.","journal-title":"Cell Death Dis"},{"issue":"10","key":"2082_CR28","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1016\/j.ymthe.2022.01.046","volume":"30","author":"Z Xu","year":"2022","unstructured":"Xu Z, et al. Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment. Mol Ther. 2022;30(10):3133\u201354.","journal-title":"Mol Ther"},{"issue":"5","key":"2082_CR29","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41419-024-06698-3","volume":"15","author":"Y Ma","year":"2024","unstructured":"Ma Y, et al. The role of circular RNAs in regulating resistance to cancer immunotherapy: mechanisms and implications. Cell Death Dis. 2024;15(5):312.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2082_CR30","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12943-020-01222-5","volume":"19","author":"PF Zhang","year":"2020","unstructured":"Zhang PF, et al. Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma. Mol Cancer. 2020;19(1):110.","journal-title":"Mol Cancer"},{"issue":"13","key":"2082_CR31","doi-asserted-by":"publisher","first-page":"2003376","DOI":"10.1002\/advs.202003376","volume":"8","author":"L Jia","year":"2021","unstructured":"Jia L, Wang Y, Wang CY. circFAT1 promotes cancer stemness and immune evasion by promoting STAT3 activation. Adv Sci (Weinh). 2021;8(13):2003376.","journal-title":"Adv Sci (Weinh)"},{"issue":"11","key":"2082_CR32","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1073\/pnas.73.11.3852","volume":"73","author":"HL Sanger","year":"1976","unstructured":"Sanger HL, et al. Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proc Natl Acad Sci U S A. 1976;73(11):3852\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5720","key":"2082_CR33","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/280339a0","volume":"280","author":"MT Hsu","year":"1979","unstructured":"Hsu MT, Coca-Prados M. Electron microscopic evidence for the circular form of RNA in the cytoplasm of eukaryotic cells. Nature. 1979;280(5720):339\u201340.","journal-title":"Nature"},{"issue":"38","key":"2082_CR34","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1038\/s41388-023-02780-w","volume":"42","author":"G Pisignano","year":"2023","unstructured":"Pisignano G, et al. Going circular: history, present, and future of circRNAs in cancer. Oncogene. 2023;42(38):2783\u2013800.","journal-title":"Oncogene"},{"issue":"9","key":"2082_CR35","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1007\/s00018-019-03345-5","volume":"77","author":"R Li","year":"2020","unstructured":"Li R, et al. CircRNA: a rising star in gastric cancer. Cell Mol Life Sci. 2020;77(9):1661\u201380.","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"2082_CR36","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1261\/rna.035667.112","volume":"19","author":"WR Jeck","year":"2013","unstructured":"Jeck WR, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 2013;19(2):141\u201357.","journal-title":"RNA"},{"issue":"9","key":"2082_CR37","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1182\/blood-2015-06-649434","volume":"127","author":"AA Alhasan","year":"2016","unstructured":"Alhasan AA, et al. Circular RNA enrichment in platelets is a signature of transcriptome degradation. Blood. 2016;127(9):e1\u201311.","journal-title":"Blood"},{"issue":"20","key":"2082_CR38","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1101\/gad.270421.115","volume":"29","author":"MC Kramer","year":"2015","unstructured":"Kramer MC, et al. Combinatorial control of Drosophila circular RNA expression by intronic repeats, hnRNPs, and SR proteins. Genes Dev. 2015;29(20):2168\u201382.","journal-title":"Genes Dev"},{"issue":"1","key":"2082_CR39","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12943-022-01615-8","volume":"21","author":"Y Xi","year":"2022","unstructured":"Xi Y, et al. CircBCAR3 accelerates esophageal cancer tumorigenesis and metastasis via sponging miR-27a-3p. Mol Cancer. 2022;21(1):145.","journal-title":"Mol Cancer"},{"issue":"6","key":"2082_CR40","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.cell.2015.02.014","volume":"160","author":"SJ Conn","year":"2015","unstructured":"Conn SJ, et al. The RNA binding protein quaking regulates formation of circRNAs. Cell. 2015;160(6):1125\u201334.","journal-title":"Cell"},{"issue":"7441","key":"2082_CR41","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11928","volume":"495","author":"S Memczak","year":"2013","unstructured":"Memczak S, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495(7441):333\u20138.","journal-title":"Nature"},{"issue":"8","key":"2082_CR42","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.7150\/thno.42174","volume":"10","author":"A Huang","year":"2020","unstructured":"Huang A, et al. Circular RNA-protein interactions: functions, mechanisms, and identification. Theranostics. 2020;10(8):3503\u201317.","journal-title":"Theranostics"},{"issue":"1","key":"2082_CR43","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13045-021-01052-y","volume":"14","author":"L Lyu","year":"2021","unstructured":"Lyu L, et al. Regulatory mechanisms, functions, and clinical significance of CircRNAs in triple-negative breast cancer. J Hematol Oncol. 2021;14(1):41.","journal-title":"J Hematol Oncol"},{"issue":"9\u201310","key":"2082_CR44","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1101\/gad.314856.118","volume":"32","author":"C Huang","year":"2018","unstructured":"Huang C, et al. A length-dependent evolutionarily conserved pathway controls nuclear export of circular RNAs. Genes Dev. 2018;32(9\u201310):639\u201344.","journal-title":"Genes Dev"},{"issue":"6","key":"2082_CR45","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.molcel.2013.08.017","volume":"51","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, et al. Circular intronic long noncoding RNAs. Mol Cell. 2013;51(6):792\u2013806.","journal-title":"Mol Cell"},{"issue":"6","key":"2082_CR46","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1007\/s11427-015-4855-y","volume":"58","author":"L Chen","year":"2015","unstructured":"Chen L, Shan G. Circular RNAs remain peculiarly unclear in biogenesis and function. Sci China Life Sci. 2015;58(6):616\u20138.","journal-title":"Sci China Life Sci"},{"issue":"1","key":"2082_CR47","doi-asserted-by":"publisher","first-page":"1424473","DOI":"10.1080\/20013078.2018.1424473","volume":"7","author":"C Preu\u00dfer","year":"2018","unstructured":"Preu\u00dfer C, et al. Selective release of circRNAs in platelet-derived extracellular vesicles. J Extracell Vesicles. 2018;7(1):1424473.","journal-title":"J Extracell Vesicles"},{"issue":"11","key":"2082_CR48","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","volume":"20","author":"LS Kristensen","year":"2019","unstructured":"Kristensen LS, et al. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675\u201391.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"2082_CR49","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s40164-023-00451-w","volume":"12","author":"XY Feng","year":"2023","unstructured":"Feng XY, et al. New insight into circRNAs: characterization, strategies, and biomedical applications. Exp Hematol Oncol. 2023;12(1):91.","journal-title":"Exp Hematol Oncol"},{"issue":"7","key":"2082_CR50","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1111\/all.15234","volume":"77","author":"BE Della","year":"2022","unstructured":"Della BE, Koch J, Baerenfaller K. Translation and emerging functions of non-coding RNAs in inflammation and immunity. Allergy. 2022;77(7):2025\u201337.","journal-title":"Allergy"},{"issue":"6","key":"2082_CR51","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.7150\/thno.56174","volume":"11","author":"Z Rong","year":"2021","unstructured":"Rong Z, et al. Circular RNA in pancreatic cancer: a novel avenue for the roles of diagnosis and treatment. Theranostics. 2021;11(6):2755\u201369.","journal-title":"Theranostics"},{"key":"2082_CR52","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1146\/annurev-cellbio-120420-125117","volume":"38","author":"L Yang","year":"2022","unstructured":"Yang L, Wilusz JE, Chen LL. Biogenesis and regulatory roles of circular RNAs. Annu Rev Cell Dev Biol. 2022;38:263\u201389.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"18","key":"2082_CR53","doi-asserted-by":"publisher","first-page":"5609","DOI":"10.1158\/0008-5472.CAN-13-1568","volume":"73","author":"TB Hansen","year":"2013","unstructured":"Hansen TB, Kjems J, Damgaard CK. Circular RNA and miR-7 in cancer. Cancer Res. 2013;73(18):5609\u201312.","journal-title":"Cancer Res"},{"issue":"1","key":"2082_CR54","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12943-023-01883-y","volume":"22","author":"Z Miao","year":"2023","unstructured":"Miao Z, et al. Hsa_circ_0136666 stimulates gastric cancer progression and tumor immune escape by regulating the miR-375\/PRKDC axis and PD-L1 phosphorylation. Mol Cancer. 2023;22(1):205.","journal-title":"Mol Cancer"},{"issue":"12","key":"2082_CR55","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1038\/s41417-022-00506-w","volume":"29","author":"Q Liu","year":"2022","unstructured":"Liu Q, et al. Targeting the androgen receptor to enhance NK cell killing efficacy in bladder cancer by modulating ADAR2\/circ_0001005\/PD-L1 signaling. Cancer Gene Ther. 2022;29(12):1988\u20132000.","journal-title":"Cancer Gene Ther"},{"issue":"1","key":"2082_CR56","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41419-020-03334-8","volume":"12","author":"M Shi","year":"2021","unstructured":"Shi M, et al. Hsa_circ_0007456 regulates the natural killer cell-mediated cytotoxicity toward hepatocellular carcinoma via the miR-6852-3p\/ICAM-1 axis. Cell Death Dis. 2021;12(1):94.","journal-title":"Cell Death Dis"},{"issue":"6","key":"2082_CR57","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1111\/cas.15365","volume":"113","author":"M Huang","year":"2022","unstructured":"Huang M, Huang X, Huang N. Exosomal circGSE1 promotes immune escape of hepatocellular carcinoma by inducing the expansion of regulatory T cells. Cancer Sci. 2022;113(6):1968\u201383.","journal-title":"Cancer Sci"},{"issue":"5","key":"2082_CR58","doi-asserted-by":"publisher","first-page":"e008491","DOI":"10.1136\/jitc-2023-008491","volume":"12","author":"Z Sun","year":"2024","unstructured":"Sun Z, et al. Exosomal circPOLQ promotes macrophage M2 polarization via activating IL-10\/STAT3 axis in a colorectal cancer model. J Immunother Cancer. 2024;12(5):e008491.","journal-title":"J Immunother Cancer."},{"issue":"1","key":"2082_CR59","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13046-023-02657-6","volume":"42","author":"J Wei","year":"2023","unstructured":"Wei J, et al. Understanding the roles and regulation patterns of circRNA on its host gene in tumorigenesis and tumor progression. J Exp Clin Cancer Res. 2023;42(1):86.","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"2082_CR60","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1016\/j.celrep.2019.02.078","volume":"26","author":"P Ji","year":"2019","unstructured":"Ji P, et al. Expanded expression landscape and prioritization of circular RNAs in mammals. Cell Rep. 2019;26(12):3444-3460.e5.","journal-title":"Cell Rep"},{"issue":"1","key":"2082_CR61","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41413-022-00208-x","volume":"10","author":"G Chen","year":"2022","unstructured":"Chen G, et al. Circular RNA circStag1 promotes bone regeneration by interacting with HuR. Bone Res. 2022;10(1):32.","journal-title":"Bone Res"},{"issue":"7","key":"2082_CR62","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1038\/s41418-018-0220-6","volume":"26","author":"Y Chen","year":"2019","unstructured":"Chen Y, et al. Circular RNA circAGO2 drives cancer progression through facilitating HuR-repressed functions of AGO2-miRNA complexes. Cell Death Differ. 2019;26(7):1346\u201364.","journal-title":"Cell Death Differ"},{"issue":"3","key":"2082_CR63","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.7150\/thno.53227","volume":"11","author":"H Liu","year":"2021","unstructured":"Liu H, et al. Circular RNA circDLC1 inhibits MMP1-mediated liver cancer progression via interaction with HuR. Theranostics. 2021;11(3):1396\u2013411.","journal-title":"Theranostics"},{"key":"2082_CR64","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.semcancer.2020.10.002","volume":"75","author":"F Li","year":"2021","unstructured":"Li F, et al. Circular RNAs in cancer: limitations in functional studies and diagnostic potential. Semin Cancer Biol. 2021;75:49\u201361.","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"2082_CR65","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/cdd.2016.133","volume":"24","author":"WW Du","year":"2017","unstructured":"Du WW, et al. Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity. Cell Death Differ. 2017;24(2):357\u201370.","journal-title":"Cell Death Differ"},{"issue":"3","key":"2082_CR66","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/s41419-022-04677-0","volume":"13","author":"Z He","year":"2022","unstructured":"He Z, et al. Autophagy-associated circRNA circATG7 facilitates autophagy and promotes pancreatic cancer progression. Cell Death Dis. 2022;13(3):233.","journal-title":"Cell Death Dis"},{"issue":"13","key":"2082_CR67","doi-asserted-by":"publisher","first-page":"e2105160","DOI":"10.1002\/advs.202105160","volume":"9","author":"Z Chen","year":"2022","unstructured":"Chen Z, et al. circREEP3 drives colorectal cancer progression via activation of FKBP10 transcription and restriction of antitumor immunity. Adv Sci (Weinh). 2022;9(13):e2105160.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"2082_CR68","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13046-024-02971-7","volume":"43","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, et al. A tumor suppressor protein encoded by circKEAP1 inhibits osteosarcoma cell stemness and metastasis by promoting vimentin proteasome degradation and activating anti-tumor immunity. J Exp Clin Cancer Res. 2024;43(1):52.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2082_CR69","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12943-023-01847-2","volume":"22","author":"Z Zhao","year":"2023","unstructured":"Zhao Z, et al. circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-\u03b2 signalling pathway-mediated activation of MMPs in pancreatic cancer. Mol Cancer. 2023;22(1):152.","journal-title":"Mol Cancer"},{"issue":"1","key":"2082_CR70","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-018-1594-y","volume":"19","author":"N Chen","year":"2018","unstructured":"Chen N, et al. A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1. Genome Biol. 2018;19(1):218.","journal-title":"Genome Biol"},{"issue":"1","key":"2082_CR71","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12943-019-1046-7","volume":"18","author":"L Wang","year":"2019","unstructured":"Wang L, et al. Circular RNA circRHOT1 promotes hepatocellular carcinoma progression by initiation of NR2F6 expression. Mol Cancer. 2019;18(1):119.","journal-title":"Mol Cancer"},{"issue":"13","key":"2082_CR72","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1038\/s41388-017-0019-9","volume":"37","author":"M Zhang","year":"2018","unstructured":"Zhang M, et al. A novel protein encoded by the circular form of the SHPRH gene suppresses glioma tumorigenesis. Oncogene. 2018;37(13):1805\u201314.","journal-title":"Oncogene"},{"issue":"1","key":"2082_CR73","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.molcel.2017.02.017","volume":"66","author":"I Legnini","year":"2017","unstructured":"Legnini I, et al. Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis. Mol Cell. 2017;66(1):22-37.e9.","journal-title":"Mol Cell"},{"issue":"5","key":"2082_CR74","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/cr.2017.31","volume":"27","author":"Y Yang","year":"2017","unstructured":"Yang Y, et al. Extensive translation of circular RNAs driven by N(6)-methyladenosine. Cell Res. 2017;27(5):626\u201341.","journal-title":"Cell Res"},{"issue":"1","key":"2082_CR75","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12943-023-01811-0","volume":"22","author":"K Li","year":"2023","unstructured":"Li K, et al. Enhancement of TKI sensitivity in lung adenocarcinoma through m6A-dependent translational repression of Wnt signaling by circ-FBXW7. Mol Cancer. 2023;22(1):103.","journal-title":"Mol Cancer"},{"issue":"1","key":"2082_CR76","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12943-019-1113-0","volume":"19","author":"Z Ma","year":"2020","unstructured":"Ma Z, et al. Circular RNAs in the tumour microenvironment. Mol Cancer. 2020;19(1):8.","journal-title":"Mol Cancer"},{"issue":"4","key":"2082_CR77","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/hep.31493","volume":"73","author":"Y Xu","year":"2021","unstructured":"Xu Y, et al. A circular RNA, cholangiocarcinoma-associated circular RNA 1, contributes to cholangiocarcinoma progression, induces angiogenesis, and disrupts vascular endothelial barriers. Hepatology. 2021;73(4):1419\u201335.","journal-title":"Hepatology"},{"issue":"5","key":"2082_CR78","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/onc.2017.361","volume":"37","author":"LS Kristensen","year":"2018","unstructured":"Kristensen LS, et al. Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2018;37(5):555\u201365.","journal-title":"Oncogene"},{"key":"2082_CR79","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.canlet.2016.03.002","volume":"387","author":"A Abdelmoez","year":"2017","unstructured":"Abdelmoez A, et al. Screening and identification of molecular targets for cancer therapy. Cancer Lett. 2017;387:3\u20139.","journal-title":"Cancer Lett"},{"issue":"3","key":"2082_CR80","doi-asserted-by":"publisher","first-page":"189104","DOI":"10.1016\/j.bbcan.2024.189104","volume":"1879","author":"A Loda","year":"2024","unstructured":"Loda A, et al. Cancer stem-like cells in uveal melanoma: novel insights and therapeutic implications. Biochim Biophys Acta Rev Cancer. 2024;1879(3):189104.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"4","key":"2082_CR81","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41571-019-0293-2","volume":"17","author":"JA Clara","year":"2020","unstructured":"Clara JA, et al. Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update. Nat Rev Clin Oncol. 2020;17(4):204\u201332.","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"2082_CR82","doi-asserted-by":"publisher","first-page":"e23719","DOI":"10.1002\/jbt.23719","volume":"38","author":"A Alqarni","year":"2024","unstructured":"Alqarni A, et al. Challenges and opportunities for cancer stem cell-targeted immunotherapies include immune checkpoint inhibitor, cancer stem cell-dendritic cell vaccine, chimeric antigen receptor immune cells, and modified exosomes. J Biochem Mol Toxicol. 2024;38(6):e23719.","journal-title":"J Biochem Mol Toxicol"},{"key":"2082_CR83","doi-asserted-by":"publisher","first-page":"112509","DOI":"10.1016\/j.intimp.2024.112509","volume":"137","author":"A Gholami","year":"2024","unstructured":"Gholami A. Cancer stem cell-derived exosomes in CD8(+) T cell exhaustion. Int Immunopharmacol. 2024;137:112509.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"2082_CR84","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.cell.2019.03.025","volume":"177","author":"Y Miao","year":"2019","unstructured":"Miao Y, et al. Adaptive immune resistance emerges from tumor-initiating stem cells. Cell. 2019;177(5):1172-1186.e14.","journal-title":"Cell"},{"issue":"19","key":"2082_CR85","doi-asserted-by":"publisher","first-page":"e148020","DOI":"10.1172\/JCI148020","volume":"131","author":"Z Chen","year":"2021","unstructured":"Chen Z, et al. Circular RNA cia-MAF drives self-renewal and metastasis of liver tumor-initiating cells via transcription factor MAFF. J Clin Invest. 2021;131(19):e148020.","journal-title":"J Clin Invest."},{"issue":"10","key":"2082_CR86","doi-asserted-by":"publisher","first-page":"e49689","DOI":"10.15252\/embr.201949689","volume":"21","author":"LP Gong","year":"2020","unstructured":"Gong LP, et al. Epstein-Barr virus-derived circular RNA LMP2A induces stemness in EBV-associated gastric cancer. EMBO Rep. 2020;21(10):e49689.","journal-title":"EMBO Rep"},{"issue":"1","key":"2082_CR87","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12943-021-01435-2","volume":"20","author":"Y Gu","year":"2021","unstructured":"Gu Y, et al. Circular RNA circIPO11 drives self-renewal of liver cancer initiating cells via Hedgehog signaling. Mol Cancer. 2021;20(1):132.","journal-title":"Mol Cancer"},{"issue":"1","key":"2082_CR88","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ymthe.2020.09.005","volume":"29","author":"X Lin","year":"2021","unstructured":"Lin X, et al. TV-circRGPD6 nanoparticle suppresses breast cancer stem cell-mediated metastasis via the miR-26b\/YAF2 axis. Mol Ther. 2021;29(1):244\u201362.","journal-title":"Mol Ther"},{"key":"2082_CR89","doi-asserted-by":"publisher","unstructured":"Hu T, et al. Cancer-derived non-coding RNAs endow tumor microenvironment with immunosuppressive properties. Wiley Interdiscip Rev RNA. 2023:e1822. https:\/\/doi.org\/10.1002\/wrna.1822.","DOI":"10.1002\/wrna.1822"},{"issue":"1","key":"2082_CR90","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12943-021-01406-7","volume":"20","author":"W Jiang","year":"2021","unstructured":"Jiang W, et al. The role of lncRNAs and circRNAs in the PD-1\/PD-L1 pathway in cancer immunotherapy. Mol Cancer. 2021;20(1):116.","journal-title":"Mol Cancer"},{"key":"2082_CR91","doi-asserted-by":"publisher","first-page":"694055","DOI":"10.3389\/fimmu.2021.694055","volume":"12","author":"B Shibru","year":"2021","unstructured":"Shibru B, et al. Detection of immune checkpoint receptors - a current challenge in clinical flow cytometry. Front Immunol. 2021;12:694055.","journal-title":"Front Immunol"},{"issue":"1","key":"2082_CR92","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12943-019-1111-2","volume":"18","author":"PF Zhang","year":"2019","unstructured":"Zhang PF, et al. Circular RNA circFGFR1 promotes progression and anti-PD-1 resistance by sponging miR-381-3p in non-small cell lung cancer cells. Mol Cancer. 2019;18(1):179.","journal-title":"Mol Cancer"},{"issue":"1","key":"2082_CR93","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41419-020-2230-9","volume":"11","author":"J Wang","year":"2020","unstructured":"Wang J, et al. circRNA-002178 act as a ceRNA to promote PDL1\/PD1 expression in lung adenocarcinoma. Cell Death Dis. 2020;11(1):32.","journal-title":"Cell Death Dis"},{"key":"2082_CR94","doi-asserted-by":"publisher","first-page":"595609","DOI":"10.3389\/fonc.2021.595609","volume":"11","author":"J Yang","year":"2021","unstructured":"Yang J, et al. Circular RNA CHST15 sponges miR-155-5p and miR-194-5p to promote the immune escape of lung cancer cells mediated by PD-L1. Front Oncol. 2021;11:595609.","journal-title":"Front Oncol"},{"issue":"1","key":"2082_CR95","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1038\/s41467-023-38232-y","volume":"14","author":"Y Dong","year":"2023","unstructured":"Dong Y, et al. Identification of CircRNA signature associated with tumor immune infiltration to predict therapeutic efficacy of immunotherapy. Nat Commun. 2023;14(1):2540.","journal-title":"Nat Commun"},{"issue":"23","key":"2082_CR96","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.1093\/hmg\/ddac155","volume":"31","author":"Q Tian","year":"2022","unstructured":"Tian Q, et al. Immunomodulatory functions of the circ_001678\/miRNA-326\/ZEB1 axis in non-small cell lung cancer via the regulation of PD-1\/PD-L1 pathway. Hum Mol Genet. 2022;31(23):4094\u2013106.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"2082_CR97","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13062-023-00397-3","volume":"18","author":"J Li","year":"2023","unstructured":"Li J, et al. Circular RNA hsa_circ_0067842 facilitates tumor metastasis and immune escape in breast cancer through HuR\/CMTM6\/PD-L1 axis. Biol Direct. 2023;18(1):48.","journal-title":"Biol Direct"},{"issue":"1","key":"2082_CR98","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40164-023-00378-2","volume":"12","author":"ZQ Chen","year":"2023","unstructured":"Chen ZQ, et al. Hypoxia-associated circPRDM4 promotes immune escape via HIF-1\u03b1 regulation of PD-L1 in hepatocellular carcinoma. Exp Hematol Oncol. 2023;12(1):17.","journal-title":"Exp Hematol Oncol"},{"issue":"19","key":"2082_CR99","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.1158\/0008-5472.CAN-20-4321","volume":"81","author":"J Ge","year":"2021","unstructured":"Ge J, et al. Epstein-Barr virus-encoded circular RNA CircBART2.2 promotes immune escape of nasopharyngeal carcinoma by regulating PD-L1. Cancer Res. 2021;81(19):5074\u201388.","journal-title":"Cancer Res"},{"issue":"1","key":"2082_CR100","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12943-021-01398-4","volume":"20","author":"Z Liu","year":"2021","unstructured":"Liu Z, et al. N(6)-methyladenosine-modified circIGF2BP3 inhibits CD8(+) T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer. Mol Cancer. 2021;20(1):105.","journal-title":"Mol Cancer"},{"issue":"Pt A","key":"2082_CR101","doi-asserted-by":"publisher","first-page":"110879","DOI":"10.1016\/j.intimp.2023.110879","volume":"124","author":"R Wang","year":"2023","unstructured":"Wang R, et al. m6A-modified circNFIX promotes ovarian cancer progression and immune escape via activating IL-6R\/JAK1\/STAT3 signaling by sponging miR-647. Int Immunopharmacol. 2023;124(Pt A):110879.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"2082_CR102","doi-asserted-by":"publisher","first-page":"188483","DOI":"10.1016\/j.bbcan.2020.188483","volume":"1875","author":"OT Olaoba","year":"2021","unstructured":"Olaoba OT, et al. Of immune checkpoint maladies and remedies: the throwing of jabs in the oncogenic ring of PDAC. Biochim Biophys Acta Rev Cancer. 2021;1875(1):188483.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2082_CR103","doi-asserted-by":"publisher","first-page":"100886","DOI":"10.1016\/j.drup.2022.100886","volume":"65","author":"Z Liu","year":"2022","unstructured":"Liu Z, et al. N6-methyladenosine-modified circular RNA QSOX1 promotes colorectal cancer resistance to anti-CTLA-4 therapy through induction of intratumoral regulatory T cells. Drug Resist Updat. 2022;65:100886.","journal-title":"Drug Resist Updat"},{"key":"2082_CR104","doi-asserted-by":"publisher","first-page":"100381","DOI":"10.1016\/j.jbo.2021.100381","volume":"30","author":"W Fang","year":"2021","unstructured":"Fang W, et al. CircRERE confers the resistance of multiple myeloma to bortezomib depending on the regulation of CD47 by exerting the sponge effect on miR-152-3p. J Bone Oncol. 2021;30:100381.","journal-title":"J Bone Oncol"},{"issue":"1","key":"2082_CR105","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s13046-021-02095-2","volume":"40","author":"YP Xu","year":"2021","unstructured":"Xu YP, et al. circHMGCS1-016 reshapes immune environment by sponging miR-1236-3p to regulate CD73 and GAL-8 expression in intrahepatic cholangiocarcinoma. J Exp Clin Cancer Res. 2021;40(1):290.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2082_CR106","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41419-023-06389-5","volume":"15","author":"L Meng","year":"2024","unstructured":"Meng L, et al. Mechanisms of immune checkpoint inhibitors: insights into the regulation of circular RNAS involved in cancer hallmarks. Cell Death Dis. 2024;15(1):3.","journal-title":"Cell Death Dis"},{"key":"2082_CR107","doi-asserted-by":"publisher","first-page":"4803","DOI":"10.2147\/IJN.S461289","volume":"19","author":"R Han","year":"2024","unstructured":"Han R, et al. Synergistic immunoregulation: harnessing CircRNAs and PiRNAs to amplify PD-1\/PD-L1 inhibition therapy. Int J Nanomedicine. 2024;19:4803\u201334.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"2082_CR108","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-019-1125-9","volume":"19","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, et al. Roles of circRNAs in the tumour microenvironment. Mol Cancer. 2020;19(1):14.","journal-title":"Mol Cancer"},{"issue":"1","key":"2082_CR109","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12943-022-01630-9","volume":"21","author":"T Xie","year":"2022","unstructured":"Xie T, et al. CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322\/CCL20\/CCR6 signaling. Mol Cancer. 2022;21(1):173.","journal-title":"Mol Cancer"},{"key":"2082_CR110","doi-asserted-by":"publisher","first-page":"111267","DOI":"10.1016\/j.intimp.2023.111267","volume":"127","author":"F Zhao","year":"2024","unstructured":"Zhao F, et al. CircMAPK1 promoted CD8 + T cell infiltration in LUAD by improving the IGF2BP1 dependent CCL5 upregulation. Int Immunopharmacol. 2024;127:111267.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"2082_CR111","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41467-020-20527-z","volume":"12","author":"B Li","year":"2021","unstructured":"Li B, et al. circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity. Nat Commun. 2021;12(1):295.","journal-title":"Nat Commun"},{"issue":"1","key":"2082_CR112","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12943-020-01191-9","volume":"19","author":"CY Wei","year":"2020","unstructured":"Wei CY, et al. Circular RNA circ_0020710 drives tumor progression and immune evasion by regulating the miR-370-3p\/CXCL12 axis in melanoma. Mol Cancer. 2020;19(1):84.","journal-title":"Mol Cancer"},{"issue":"1","key":"2082_CR113","doi-asserted-by":"publisher","first-page":"7243","DOI":"10.1038\/s41467-022-34872-8","volume":"13","author":"R Piras","year":"2022","unstructured":"Piras R, et al. circCsnk1g3- and circAnkib1-regulated interferon responses in sarcoma promote tumorigenesis by shaping the immune microenvironment. Nat Commun. 2022;13(1):7243.","journal-title":"Nat Commun"},{"issue":"1","key":"2082_CR114","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12943-020-01213-6","volume":"19","author":"XY Huang","year":"2020","unstructured":"Huang XY, et al. Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p\/snail\/DPP4 axis. Mol Cancer. 2020;19(1):92.","journal-title":"Mol Cancer"},{"issue":"1","key":"2082_CR115","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12943-024-01969-1","volume":"23","author":"XY Huang","year":"2024","unstructured":"Huang XY, et al. Correction: circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p\/snail\/DPP4 axis. Mol Cancer. 2024;23(1):44.","journal-title":"Mol Cancer"},{"issue":"3","key":"2082_CR116","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.it.2020.01.001","volume":"41","author":"F Salerno","year":"2020","unstructured":"Salerno F, Turner M, Wolkers MC. Dynamic post-transcriptional events governing CD8(+) T cell homeostasis and effector function. Trends Immunol. 2020;41(3):240\u201354.","journal-title":"Trends Immunol"},{"issue":"5","key":"2082_CR117","doi-asserted-by":"publisher","first-page":"e2100650","DOI":"10.1002\/adhm.202100650","volume":"11","author":"S Ruan","year":"2022","unstructured":"Ruan S, et al. Extracellular vesicles as an advanced delivery biomaterial for precision cancer immunotherapy. Adv Healthc Mater. 2022;11(5):e2100650.","journal-title":"Adv Healthc Mater"},{"issue":"1","key":"2082_CR118","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41392-023-01382-y","volume":"8","author":"M Zhang","year":"2023","unstructured":"Zhang M, et al. Engineered exosomes from different sources for cancer-targeted therapy. Signal Transduct Target Ther. 2023;8(1):124.","journal-title":"Signal Transduct Target Ther"},{"issue":"17","key":"2082_CR119","doi-asserted-by":"publisher","first-page":"e2205739","DOI":"10.1002\/smll.202205739","volume":"19","author":"Y Pan","year":"2023","unstructured":"Pan Y, et al. Extracellular vesicles as delivery shippers for noncoding RNA-based modulation of angiogenesis: insights from ischemic stroke and cancer. Small. 2023;19(17):e2205739.","journal-title":"Small"},{"issue":"3","key":"2082_CR120","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s12276-022-00744-w","volume":"54","author":"QW Liu","year":"2022","unstructured":"Liu QW, He Y, Xu WW. Molecular functions and therapeutic applications of exosomal noncoding RNAs in cancer. Exp Mol Med. 2022;54(3):216\u201325.","journal-title":"Exp Mol Med"},{"key":"2082_CR121","doi-asserted-by":"publisher","unstructured":"Muskan M, et al. Therapeutic potential of RNA-enriched extracellular vesicles: the next generation in RNA delivery via biogenic nanoparticles.\u00a0Mol Ther. 2024:S1525-0016(24)00094-7. https:\/\/doi.org\/10.1016\/j.ymthe.2024.02.025.","DOI":"10.1016\/j.ymthe.2024.02.025"},{"issue":"1","key":"2082_CR122","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12943-021-01448-x","volume":"20","author":"SW Chen","year":"2021","unstructured":"Chen SW, et al. Cancer cell-derived exosomal circUSP7 induces CD8(+) T cell dysfunction and anti-PD1 resistance by regulating the miR-934\/SHP2 axis in NSCLC. Mol Cancer. 2021;20(1):144.","journal-title":"Mol Cancer"},{"issue":"1","key":"2082_CR123","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s13046-022-02505-z","volume":"41","author":"J Gao","year":"2022","unstructured":"Gao J, et al. Exosomal circZNF451 restrains anti-PD1 treatment in lung adenocarcinoma via polarizing macrophages by complexing with TRIM56 and FXR1. J Exp Clin Cancer Res. 2022;41(1):295.","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"2082_CR124","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.ymthe.2022.01.022","volume":"30","author":"C Yang","year":"2022","unstructured":"Yang C, et al. Exosome-derived circTRPS1 promotes malignant phenotype and CD8+ T cell exhaustion in bladder cancer microenvironments. Mol Ther. 2022;30(3):1054\u201370.","journal-title":"Mol Ther"},{"key":"2082_CR125","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","volume":"16","author":"S Bagchi","year":"2021","unstructured":"Bagchi S, Yuan R, Engleman EG. Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance. Annu Rev Pathol. 2021;16:223\u201349.","journal-title":"Annu Rev Pathol"},{"key":"2082_CR126","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2018.01.005","volume":"141","author":"E Hong","year":"2019","unstructured":"Hong E, Dobrovolskaia MA. Addressing barriers to effective cancer immunotherapy with nanotechnology: achievements, challenges, and roadmap to the next generation of nanoimmunotherapeutics. Adv Drug Deliv Rev. 2019;141:3\u201322.","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"2082_CR127","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ccell.2020.03.017","volume":"37","author":"AJ Schoenfeld","year":"2020","unstructured":"Schoenfeld AJ, Hellmann MD. Acquired resistance to immune checkpoint inhibitors. Cancer Cell. 2020;37(4):443\u201355.","journal-title":"Cancer Cell"},{"issue":"1","key":"2082_CR128","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12943-023-01807-w","volume":"22","author":"M Chehelgerdi","year":"2023","unstructured":"Chehelgerdi M, Chehelgerdi M. The use of RNA-based treatments in the field of cancer immunotherapy. Mol Cancer. 2023;22(1):106.","journal-title":"Mol Cancer"},{"issue":"8016","key":"2082_CR129","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/d41586-024-01717-x","volume":"630","author":"E Dolgin","year":"2024","unstructured":"Dolgin E. How personalized cancer vaccines could keep tumours from coming back. Nature. 2024;630(8016):290\u20132.","journal-title":"Nature"},{"issue":"10","key":"2082_CR130","doi-asserted-by":"publisher","first-page":"e450","DOI":"10.1016\/S1470-2045(22)00372-2","volume":"23","author":"CL Lorentzen","year":"2022","unstructured":"Lorentzen CL, et al. Clinical advances and ongoing trials on mRNA vaccines for cancer treatment. Lancet Oncol. 2022;23(10):e450\u20138.","journal-title":"Lancet Oncol"},{"issue":"3","key":"2082_CR131","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/14760584.2018.1434000","volume":"17","author":"WS Bowen","year":"2018","unstructured":"Bowen WS, et al. Current challenges for cancer vaccine adjuvant development. Expert Rev Vaccines. 2018;17(3):207\u201315.","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"2082_CR132","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41392-023-01561-x","volume":"8","author":"D Niu","year":"2023","unstructured":"Niu D, Wu Y, Lian J. Circular RNA vaccine in disease prevention and treatment. Signal Transduct Target Ther. 2023;8(1):341.","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"2082_CR133","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.cell.2022.03.044","volume":"185","author":"L Qu","year":"2022","unstructured":"Qu L, et al. Circular RNA vaccines against SARS-CoV-2 and emerging variants. Cell. 2022;185(10):1728-1744.e16.","journal-title":"Cell"},{"issue":"1","key":"2082_CR134","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.molcel.2019.07.016","volume":"76","author":"YG Chen","year":"2019","unstructured":"Chen YG, et al. N6-methyladenosine modification controls circular RNA immunity. Mol Cell. 2019;76(1):96-109.e9.","journal-title":"Mol Cell"},{"key":"2082_CR135","doi-asserted-by":"publisher","first-page":"114826","DOI":"10.1016\/j.addr.2023.114826","volume":"197","author":"YT Loan","year":"2023","unstructured":"Loan YT, et al. Clinical delivery of circular RNA: lessons learned from RNA drug development. Adv Drug Deliv Rev. 2023;197:114826.","journal-title":"Adv Drug Deliv Rev"},{"issue":"14","key":"2082_CR136","doi-asserted-by":"publisher","first-page":"6422","DOI":"10.7150\/thno.77350","volume":"12","author":"H Li","year":"2022","unstructured":"Li H, et al. Circular RNA cancer vaccines drive immunity in hard-to-treat malignancies. Theranostics. 2022;12(14):6422\u201336.","journal-title":"Theranostics"},{"issue":"8","key":"2082_CR137","doi-asserted-by":"crossref","first-page":"e667","DOI":"10.1002\/mco2.667","volume":"5","author":"F Wang","year":"2024","unstructured":"Wang F, et al. Circular RNA-based neoantigen vaccine for hepatocellular carcinoma immunotherapy. MedComm (2020). 2024;5(8):e667.","journal-title":"MedComm (2020)"},{"issue":"3","key":"2082_CR138","doi-asserted-by":"publisher","first-page":"e008402","DOI":"10.1136\/jitc-2023-008402","volume":"12","author":"Y Ren","year":"2024","unstructured":"Ren Y, et al. Circular RNA as a source of neoantigens for cancer vaccines. J Immunother Cancer. 2024;12(3):e008402.","journal-title":"J Immunother Cancer."}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-024-02082-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-024-02082-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-024-02082-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T21:37:21Z","timestamp":1732657041000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-024-02082-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,21]]},"references-count":138,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2082"],"URL":"https:\/\/doi.org\/10.1186\/s12943-024-02082-z","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,21]]},"assertion":[{"value":"2 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"171"}}